Literature DB >> 12890709

Purification of a neuroprotective component of Parawixia bistriata spider venom that enhances glutamate uptake.

Andréia Cristina Karklin Fontana1, Renato Guizzo, Renê de Oliveira Beleboni, Antonio Renato Meirelles E Silva, Norberto Cysne Coimbra, Susan G Amara, Wagner Ferreira dos Santos, Joaquim Coutinho-Netto.   

Abstract

(1) In this study, we examined the effects of crude venom from the spider Parawixia bistriata on glutamate and GABA uptake into synaptosomes prepared from rat cerebral cortex. Addition of venom to cortical synaptosomes stimulated glutamate uptake and inhibited GABA uptake in a concentration-dependent manner. (2) The venom was fractionated using reverse-phase high-performance liquid chromatography on a preparative column. The fraction that retained glutamate uptake-stimulating activity was further purified on a reverse-phase analytical column followed by ion-exchange chromatography. (3) The active fraction, referred to as PbTx1.2.3, stimulated glutamate uptake in synaptosomes without changing the K(M) value, and did not affect GABA uptake. Additional experiments showed that the enhancement of glutamate uptake by PbTx1.2.3 occurs when ionotropic glutamate receptors or voltage-gated sodium and calcium channels are completely inhibited or when GABA receptors and potassium channels are activated, indicating that the compound may have a direct action on the transporters. (4) In an experimental model for glaucoma in which rat retinas are subjected to ischemia followed by reperfusion, PbTx1.2.3 protected neurons from excitotoxic death in both outer and inner nuclear layers, and ganglion cell layers. (5) This active spider venom component may serve as a basis for designing therapeutic drugs that increase glutamate clearance and limit neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12890709      PMCID: PMC1573954          DOI: 10.1038/sj.bjp.0705352

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  60 in total

1.  The isolation of nerve endings from brain: an electron-microscopic study of cell fragments derived by homogenization and centrifugation.

Authors:  E G GRAY; V P WHITTAKER
Journal:  J Anat       Date:  1962-01       Impact factor: 2.610

Review 2.  Spider toxins affecting glutamate receptors: polyamines in therapeutic neurochemistry.

Authors:  P N Usherwood; I S Blagbrough
Journal:  Pharmacol Ther       Date:  1991-11       Impact factor: 12.310

3.  Region-specific loss of glutamate innervation in Alzheimer's disease.

Authors:  J Hardy; R Cowburn; A Barton; G Reynolds; E Lofdahl; A M O'Carroll; P Wester; B Winblad
Journal:  Neurosci Lett       Date:  1987-01-02       Impact factor: 3.046

4.  Non-vesicular release of glutamate from glial cells by reversed electrogenic glutamate uptake.

Authors:  M Szatkowski; B Barbour; D Attwell
Journal:  Nature       Date:  1990-11-29       Impact factor: 49.962

5.  Structure-activity relationships of philanthotoxin analogs and polyamines on N-methyl-D-aspartate and nicotinic acetylcholine receptors.

Authors:  N Anis; S Sherby; R Goodnow; M Niwa; K Konno; T Kallimopoulos; R Bukownik; K Nakanishi; P Usherwood; A Eldefrawi
Journal:  J Pharmacol Exp Ther       Date:  1990-09       Impact factor: 4.030

6.  Diversity of Conus neuropeptides.

Authors:  B M Olivera; J Rivier; C Clark; C A Ramilo; G P Corpuz; F C Abogadie; E E Mena; S R Woodward; D R Hillyard; L J Cruz
Journal:  Science       Date:  1990-07-20       Impact factor: 47.728

7.  Presynaptic effects of spider toxins: increase of high affinity uptake in the arthropod peripheral glutamatergic system.

Authors:  J van Marle; T Piek; H Karst; A Lind; J van Weeren-Kramer
Journal:  Experientia       Date:  1989-02-15

8.  Glutamate release in experimental ischaemia of the retina: an approach using microdialysis.

Authors:  P Louzada-Júnior; J J Dias; W F Santos; J J Lachat; H F Bradford; J Coutinho-Netto
Journal:  J Neurochem       Date:  1992-07       Impact factor: 5.372

9.  Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis.

Authors:  J D Rothstein; L J Martin; R W Kuncl
Journal:  N Engl J Med       Date:  1992-05-28       Impact factor: 91.245

10.  Quantitation of ischemic damage in the rat retina.

Authors:  W F Hughes
Journal:  Exp Eye Res       Date:  1991-11       Impact factor: 3.467

View more
  18 in total

1.  Pro- and Anticonvulsant Effects of the Ant Dinoponera quadriceps (Kempf) Venom in Mice.

Authors:  D A M F Nôga; F C Cagni; J R Santos; D Silva; D L O Azevedo; A Araújo; R H Silva; A M Ribeiro
Journal:  Neotrop Entomol       Date:  2015-06-05       Impact factor: 1.434

Review 2.  Glutamate transporter EAAT2: regulation, function, and potential as a therapeutic target for neurological and psychiatric disease.

Authors:  Kou Takahashi; Joshua B Foster; Chien-Liang Glenn Lin
Journal:  Cell Mol Life Sci       Date:  2015-06-02       Impact factor: 9.261

3.  The Concise Guide to PHARMACOLOGY 2013/14: transporters.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

Review 4.  Therapeutically targeting astrocytes with stem and progenitor cell transplantation following traumatic spinal cord injury.

Authors:  Aditi Falnikar; Ke Li; Angelo C Lepore
Journal:  Brain Res       Date:  2014-09-22       Impact factor: 3.252

Review 5.  Molecular targets for antiepileptic drug development.

Authors:  Brian S Meldrum; Michael A Rogawski
Journal:  Neurotherapeutics       Date:  2007-01       Impact factor: 7.620

Review 6.  Reactive astrocytes as therapeutic targets for CNS disorders.

Authors:  Mary E Hamby; Michael V Sofroniew
Journal:  Neurotherapeutics       Date:  2010-10       Impact factor: 7.620

7.  Neuroprotective Effects of the Glutamate Transporter Activator (R)-(-)-5-methyl-1-nicotinoyl-2-pyrazoline (MS-153) following Traumatic Brain Injury in the Adult Rat.

Authors:  Andréia Cristina Fontana; Douglas P Fox; Argie Zoubroulis; Ole Valente Mortensen; Ramesh Raghupathi
Journal:  J Neurotrauma       Date:  2015-09-24       Impact factor: 5.269

Review 8.  Transporters for L-glutamate: an update on their molecular pharmacology and pathological involvement.

Authors:  P M Beart; R D O'Shea
Journal:  Br J Pharmacol       Date:  2006-11-06       Impact factor: 8.739

Review 9.  Astrocyte elevated gene-1 (AEG-1) and the A(E)Ging HIV/AIDS-HAND.

Authors:  Neha Vartak-Sharma; Shruthi Nooka; Anuja Ghorpade
Journal:  Prog Neurobiol       Date:  2016-04-14       Impact factor: 11.685

10.  Neurobiology, Functions, and Relevance of Excitatory Amino Acid Transporters (EAATs) to Treatment of Refractory Epilepsy.

Authors:  Aleksey V Zaitsev; Ilya V Smolensky; Pascal Jorratt; Saak V Ovsepian
Journal:  CNS Drugs       Date:  2020-11       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.